U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07218211) titled 'Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP' on Oct. 03.
Brief Summary: The purpose of this project is to test a culturally-tailored, community-delivered long-acting injectable PrEP (lenacapavir) program for Latine gay and bisexual men (GBM) and transgender women (TGW). The objective is to evaluate whether this intervention demonstrates greater persistence on lenacapavir for Latine GBM and TGW compared with what has been observed historically at the Duke PrEP Clinic.
Study Start Date: Jan. 05, 2026
Study Type: INTERVENTIONAL
Condition:
HIV Prevention
HIV Pre-exposur...